HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dafu Yang Selected Research

Adenocarcinoma of Lung

1/2024Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dafu Yang Research Topics

Disease

2Lung Neoplasms (Lung Cancer)
11/2021 - 01/2020
1Adenocarcinoma of Lung
01/2024
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024
1Neoplasms (Cancer)
12/2020

Drug/Important Bio-Agent (IBA)

1entrectinibIBA
01/2024
1Anaplastic Lymphoma KinaseIBA
01/2024
1Tyrosine Kinase InhibitorsIBA
01/2024
1brigatinibIBA
01/2024
1SilverIBA
11/2021
1Circulating Tumor DNAIBA
12/2020
1Phosphotransferases (Kinase)IBA
01/2020

Therapy/Procedure

1Therapeutics
01/2020